Interactive support avatar for cancer treatment education
Part of Cancer clinical trials.
This study tests a digital avatar that helps you learn about your cancer treatment. It aims to make understanding your treatment easier and more interactive, helping you feel more prepared.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are starting a new cancer treatment at Erasmus MC.
- You can read and speak Dutch.
- You have internet access.
- You can use a computer, smartphone, or tablet.
- You are able to give informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study builds a database of videos and voice recordings from people with cancer, both with and without pain. The goal is to train artificial intelligence (AI) to automatically recognize pain, which could help doctors better manage it in the future.
This trial tests whether an AI-powered chatbot can help people with cancer feel better emotionally and improve their quality of life. You can join if you are currently in cancer treatment, feeling distressed, and have a smartphone.
This study is testing an interactive AI-based service to support the mental health of people with cancer. It is designed to help during or after cancer treatment.
This trial tests a supportive care program using an avatar to help patients going through a stem cell transplant. It aims to improve your experience and outcomes during recovery.
This study tests a digital tool that uses pictures and simple visuals to help you understand your cancer treatment options. The goal is to make the experience better for you, your family, and your doctors.
This trial tests a social virtual reality tool designed to help adolescents and young adults with cancer (and their caregivers) learn about their condition and treatment. It focuses on patients who are newly diagnosed and will receive chemotherapy through a central line.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.